- Report
- October 2024
- 180 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 153 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- November 2024
- 49 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- April 2023
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 112 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- March 2024
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- June 2023
- 577 Pages
Global
From €9539EUR$9,995USD£7,992GBP
- Report
- June 2023
- 1041 Pages
Europe
From €8585EUR$8,995USD£7,193GBP
- Report
- March 2023
- 479 Pages
Europe
From €8585EUR$8,995USD£7,193GBP
- Report
- October 2023
- 88 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- December 2021
- 251 Pages
Global
From €3543EUR$3,712USD£2,968GBP
The Carotid Stent market is a subset of the larger Stent market, which is composed of medical devices used to treat narrowed or blocked arteries. Carotid Stents are specifically designed to treat carotid artery disease, which is caused by the buildup of plaque in the carotid arteries. This buildup can lead to stroke or other serious medical conditions. Carotid Stents are inserted into the carotid artery to open the artery and restore blood flow.
Carotid Stents are typically made of metal or plastic and are inserted using a catheter. The procedure is minimally invasive and can be done in a hospital or outpatient setting. Carotid Stents are often used in combination with other treatments, such as medications or lifestyle changes, to reduce the risk of stroke.
Some companies in the Carotid Stent market include Abbott, Boston Scientific, Medtronic, and Terumo. Show Less Read more
